chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: tender arm but was still able to do her daily activities with no issues; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (tender arm but was still able to do her daily activities with no issues) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (tender arm but was still able to do her daily activities with no issues). At the time of the report, VACCINATION SITE PAIN (tender arm but was still able to do her daily activities with no issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment drugs were reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema
Clinical narrative: Arm was sore; Red blotch 4 inch long and 6 inch wide at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore) and VACCINATION SITE ERYTHEMA (Red blotch 4 inch long and 6 inch wide at injection site) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore) and VACCINATION SITE ERYTHEMA (Red blotch 4 inch long and 6 inch wide at injection site). At the time of the report, PAIN IN EXTREMITY (Arm was sore) and VACCINATION SITE ERYTHEMA (Red blotch 4 inch long and 6 inch wide at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No relevant concomitant medications were reported. Treatment details included ice patch and hot compress.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Pyrexia, Somnolence
Clinical narrative: can barely get up; no appetite; weakness; fever; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (can barely get up), DECREASED APPETITE (no appetite), ASTHENIA (weakness) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (weakness) and PYREXIA (fever). On an unknown date, the patient experienced SOMNOLENCE (can barely get up). At the time of the report, SOMNOLENCE (can barely get up), DECREASED APPETITE (no appetite), ASTHENIA (weakness) and PYREXIA (fever) outcome was unknown.            Treatment Drugs: Tylenol No concomitant drugs are provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2021: No specific follow-up information recorded.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site pain, Injection site pruritus
Clinical narrative: Bruise on the arm at the injection site after second dose; Itching at the injection site after the second dose; Pain at the injection site after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE BRUISING (Bruise on the arm at the injection site after second dose), INJECTION SITE PRURITUS (Itching at the injection site after the second dose) and INJECTION SITE PAIN (Pain at the injection site after the second dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced INJECTION SITE BRUISING (Bruise on the arm at the injection site after second dose), INJECTION SITE PRURITUS (Itching at the injection site after the second dose) and INJECTION SITE PAIN (Pain at the injection site after the second dose). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] for Itching and Pain, at a dose of 1 g. At the time of the report, INJECTION SITE BRUISING (Bruise on the arm at the injection site after second dose), INJECTION SITE PRURITUS (Itching at the injection site after the second dose) and INJECTION SITE PAIN (Pain at the injection site after the second dose) outcome was unknown.            No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-029506 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Heart rate, Heart rate increased, Oxygen saturation, Pyrexia
Clinical narrative: Heart rate was higher than normal; Sore arm; Low grade fever; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (Heart rate was higher than normal), VACCINATION SITE PAIN (Sore arm), PYREXIA (Low grade fever) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced HEART RATE INCREASED (Heart rate was higher than normal), VACCINATION SITE PAIN (Sore arm), PYREXIA (Low grade fever) and CHILLS (Chills).   The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency.   At the time of the report, HEART RATE INCREASED (Heart rate was higher than normal), VACCINATION SITE PAIN (Sore arm), PYREXIA (Low grade fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 81-100-132 (High) Patient's heart rate was 81 while sleeping and 100 while awake but no exercising. On one of the night, heart rate was 132. On an unknown date, Oxygen saturation: normal normal.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Heart rate was higher than normal; Sore arm; Low grade fever; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (Heart rate was higher than normal), VACCINATION SITE PAIN (Sore arm), PYREXIA (Low grade fever) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced HEART RATE INCREASED (Heart rate was higher than normal), VACCINATION SITE PAIN (Sore arm), PYREXIA (Low grade fever) and CHILLS (Chills).   The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency.   At the time of the report, HEART RATE INCREASED (Heart rate was higher than normal), VACCINATION SITE PAIN (Sore arm), PYREXIA (Low grade fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 81-100-132 (High) Patient's heart rate was 81 while sleeping and 100 while awake but no exercising. On one of the night, heart rate was 132. On an unknown date, Oxygen saturation: normal normal.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Hyperhidrosis
Clinical narrative: may have been sweating in the night but she has no fever.; experienced hoarseness; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (experienced hoarseness) and HYPERHIDROSIS (may have been sweating in the night but she has no fever.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced DYSPHONIA (experienced hoarseness). On 01-Mar-2021, the patient experienced HYPERHIDROSIS (may have been sweating in the night but she has no fever.). At the time of the report, DYSPHONIA (experienced hoarseness) and HYPERHIDROSIS (may have been sweating in the night but she has no fever.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity, Pyrexia
Clinical narrative: Pain in arm; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), CHILLS (Chills) and PYREXIA (Fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011C20A) for COVID-19 vaccination.    Co-suspect product included non-company product ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) for an unknown indication.    The patient's past medical history included No adverse event (Medical history was not reported.). Concomitant products included QUINAPRIL and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) (unknown route) at an unspecified dose. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Pain in arm), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.             Treatment information included Ice pack. Action taken with mRNA-1273 in response to the event was not applicable   Reporter did not allow further contact
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Headache, Night sweats, Pain in extremity
Clinical narrative: headache; feeling like finger prick in his right hand; woke up in the middle of the night perspiring; his right fingers are purple every time; Strong pain on his right fingers; chest pain; difficulty breathing; red spot in his finger; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (feeling like finger prick in his right hand), NIGHT SWEATS (woke up in the middle of the night perspiring), SKIN DISCOLOURATION (his right fingers are purple every time), PAIN IN EXTREMITY (Strong pain on his right fingers) and CHEST PAIN (chest pain) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Scleroderma (Diagnosed with scleroderma five years ago.) since an unknown date. Concomitant products included MYCOPHENOLATE MOFETIL (MYCOPHENOLATE), AMLODIPINE and OMEPRAZOLE for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PARAESTHESIA (feeling like finger prick in his right hand), NIGHT SWEATS (woke up in the middle of the night perspiring), SKIN DISCOLOURATION (his right fingers are purple every time), PAIN IN EXTREMITY (Strong pain on his right fingers), CHEST PAIN (chest pain), DYSPNOEA (difficulty breathing) and RASH MACULAR (red spot in his finger). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Headache, at an unspecified dose and frequency. On 21-Jan-2021, CHEST PAIN (chest pain) and DYSPNOEA (difficulty breathing) had resolved. On 24-Jan-2021, NIGHT SWEATS (woke up in the middle of the night perspiring) had resolved. At the time of the report, PARAESTHESIA (feeling like finger prick in his right hand), SKIN DISCOLOURATION (his right fingers are purple every time), PAIN IN EXTREMITY (Strong pain on his right fingers), RASH MACULAR (red spot in his finger) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Rash macular, Skin discolouration
Clinical narrative: headache; feeling like finger prick in his right hand; woke up in the middle of the night perspiring; his right fingers are purple every time; Strong pain on his right fingers; chest pain; difficulty breathing; red spot in his finger; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (feeling like finger prick in his right hand), NIGHT SWEATS (woke up in the middle of the night perspiring), SKIN DISCOLOURATION (his right fingers are purple every time), PAIN IN EXTREMITY (Strong pain on his right fingers) and CHEST PAIN (chest pain) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Scleroderma (Diagnosed with scleroderma five years ago.) since an unknown date. Concomitant products included MYCOPHENOLATE MOFETIL (MYCOPHENOLATE), AMLODIPINE and OMEPRAZOLE for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PARAESTHESIA (feeling like finger prick in his right hand), NIGHT SWEATS (woke up in the middle of the night perspiring), SKIN DISCOLOURATION (his right fingers are purple every time), PAIN IN EXTREMITY (Strong pain on his right fingers), CHEST PAIN (chest pain), DYSPNOEA (difficulty breathing) and RASH MACULAR (red spot in his finger). On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and IBUPROFEN ongoing since an unknown date for Headache, at an unspecified dose and frequency. On 21-Jan-2021, CHEST PAIN (chest pain) and DYSPNOEA (difficulty breathing) had resolved. On 24-Jan-2021, NIGHT SWEATS (woke up in the middle of the night perspiring) had resolved. At the time of the report, PARAESTHESIA (feeling like finger prick in his right hand), SKIN DISCOLOURATION (his right fingers are purple every time), PAIN IN EXTREMITY (Strong pain on his right fingers), RASH MACULAR (red spot in his finger) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Positive covid test; Fever; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive covid test), PYREXIA (Fever) and MYALGIA (Body ache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced PYREXIA (Fever) and MYALGIA (Body ache). On 26-Jan-2021, the patient experienced COVID-19 (Positive covid test). At the time of the report, COVID-19 (Positive covid test), PYREXIA (Fever) and MYALGIA (Body ache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.         No relevant concomitant medications were reported. Treatment information was took medicine and the symptoms were gone in three days.   Reporter did not allow further contact
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: upset stomach; fatigue; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset stomach), FATIGUE (fatigue), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX on 04-Dec-2020. Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) from 14-Feb-2021 to 14-Feb-2021 for Shingles.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach), FATIGUE (fatigue), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). At the time of the report, ABDOMINAL DISCOMFORT (upset stomach), FATIGUE (fatigue), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2021: Follow up received and contains no new information
Sex: M
Vaccine: COVID19
Symptoms: Skin laceration
Clinical narrative: got a cut; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LACERATION (got a cut) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced SKIN LACERATION (got a cut). The patient was treated with TETANUS VACCINE on 15-Feb-2021 at a dose of 1 dosage form. At the time of the report, SKIN LACERATION (got a cut) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant drugs were reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Vaccination site pain
Clinical narrative: Sore arm; Dizziness; Extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness) and FATIGUE (Extreme fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder since 1975, Blood pressure high since 1975, Anxiety since 1975, Acid reflux (esophageal) and Penicillin allergy. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), PAROXETIN [PAROXETINE] for Anxiety, IRBESARTAN and EZETIMIBE for Blood pressure high, ATORVASTATIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness) and FATIGUE (Extreme fatigue). On 13-Feb-2021, PAIN IN EXTREMITY (Sore arm), DIZZINESS (Dizziness) and FATIGUE (Extreme fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Completed ADR Form included updated reporter details, patient demographic details, medical history, allergic information, concomitant medication, event outcome details.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Malaise, Myalgia, Nausea, Pyrexia
Clinical narrative: nausea; vomiting; cheeks were blushed; didn't feel good; fever; pain in arm; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), VACCINATION SITE PAIN (pain in arm), MYALGIA (body aches), NAUSEA (nausea) and VOMITING (vomiting) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Feb-2021, the patient experienced PYREXIA (fever), VACCINATION SITE PAIN (pain in arm), MYALGIA (body aches) and MALAISE (didn't feel good).   On 11-Feb-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting) and FLUSHING (cheeks were blushed).   On 11-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE PAIN (pain in arm), MYALGIA (body aches), NAUSEA (nausea), VOMITING (vomiting), FLUSHING (cheeks were blushed) and MALAISE (didn't feel good) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vomiting
Clinical narrative: nausea; vomiting; cheeks were blushed; didn't feel good; fever; pain in arm; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), VACCINATION SITE PAIN (pain in arm), MYALGIA (body aches), NAUSEA (nausea) and VOMITING (vomiting) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Feb-2021, the patient experienced PYREXIA (fever), VACCINATION SITE PAIN (pain in arm), MYALGIA (body aches) and MALAISE (didn't feel good).   On 11-Feb-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting) and FLUSHING (cheeks were blushed).   On 11-Feb-2021, PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE PAIN (pain in arm), MYALGIA (body aches), NAUSEA (nausea), VOMITING (vomiting), FLUSHING (cheeks were blushed) and MALAISE (didn't feel good) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Injection site pruritus, Peripheral swelling, Vaccination site reaction
Clinical narrative: injection site reaction; welling on her arm, 3" or 4" in; burning; red; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (injection site reaction), PERIPHERAL SWELLING (welling on her arm, 3" or 4" in), BURNING SENSATION (burning), ERYTHEMA (red) and INJECTION SITE PRURITUS (itchy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included Chicken pox (historical condition include chicken pox).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced VACCINATION SITE REACTION (injection site reaction), PERIPHERAL SWELLING (welling on her arm, 3" or 4" in), BURNING SENSATION (burning), ERYTHEMA (red) and INJECTION SITE PRURITUS (itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION (injection site reaction), PERIPHERAL SWELLING (welling on her arm, 3" or 4" in), BURNING SENSATION (burning), ERYTHEMA (red) and INJECTION SITE PRURITUS (itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment details included Benadryl 25mg liquid and ice pack.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site erythema, Vaccination site pruritus, Vitreous floaters
Clinical narrative: Redness at the injection site; Itchiness at the injection site; floaters in his left eye; arm muscle was swollen; A spontaneous report was received from a consumer concerning a 77-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness at the injection site, itchiness at the injection site, arm muscle was swollen, floaters in his left eye.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route in the right arm for prophylaxis of COVID-19 infection.  On 27 Jan 2021, after receiving the first dose of mRNA-1273, the patient experienced arm muscle was swollen.  On 28 Jan 2021, the patient experienced the event redness at the injection site, itchiness at the injection site and floaters in his left eye. The patient still experienced redness and itchiness at the injection site.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), redness at the injection site, itchiness at the injection site was not resolved.  The outcome of event(s), arm muscle was swollen, floaters in his left eye was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Breast swelling, Breast tenderness, Myalgia, Paraesthesia oral
Clinical narrative: Hard breast; Tingling Tongue; Tingling mouth; Knee arthritis; Tingling lips; Extremely painful along with entire body; entire body inflamed with arthritis; Breast Swelling,Breast engorged , enlarged,areola very enlarged; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (Breast Swelling,Breast engorged , enlarged,areola very enlarged), BREAST TENDERNESS (Hard breast), PARAESTHESIA ORAL (Tingling Tongue), PARAESTHESIA ORAL (Tingling mouth) and ARTHRITIS (Knee arthritis) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast reduction (Patient had a breast reduction 32 years ago). Concurrent medical conditions included Acid reflux (esophageal), Drug allergy (Morphine), Drug allergy (Protonix) and Drug allergy (Reglan). Concomitant products included FAMOTIDINE and CALCIUM for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced BREAST SWELLING (Breast Swelling,Breast engorged , enlarged,areola very enlarged), PARAESTHESIA ORAL (Tingling mouth), ARTHRITIS (Knee arthritis), PARAESTHESIA ORAL (Tingling lips), MYALGIA (Extremely painful along with entire body) and ARTHRITIS (entire body inflamed with arthritis). On 13-Feb-2021, the patient experienced BREAST TENDERNESS (Hard breast) and PARAESTHESIA ORAL (Tingling Tongue). At the time of the report, BREAST SWELLING (Breast Swelling,Breast engorged , enlarged,areola very enlarged), BREAST TENDERNESS (Hard breast), PARAESTHESIA ORAL (Tingling Tongue), PARAESTHESIA ORAL (Tingling mouth), ARTHRITIS (Knee arthritis), PARAESTHESIA ORAL (Tingling lips), MYALGIA (Extremely painful along with entire body) and ARTHRITIS (entire body inflamed with arthritis) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On Saturday Patient took Famotidine and antacid tablet for 2 days.  Patient feels Constantly thirsty.  Patient used ice pack and heating pads for months and continues today on breast and knees  No Treatment medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Medical history updated in patient tab, New events are added in events tab. On 11-Jul-2021: Non significant follow up-adr form copies updated
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Oral discomfort, Oral pain
Clinical narrative: Burning in her mouth; Terrible mouth sores on my tongue, inner lips, and gums.; This spontaneous case was reported by a consumer and describes the occurrence of ORAL PAIN (Terrible mouth sores on my tongue, inner lips, and gums.) and ORAL DISCOMFORT (Burning in her mouth) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced ORAL PAIN (Terrible mouth sores on my tongue, inner lips, and gums.). On 02-Feb-2021, the patient experienced ORAL DISCOMFORT (Burning in her mouth). The patient was treated with ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETICONE (MAALOX ADVANCED [ALUMINIUM HYDROXIDE;MAGNESIUM HYDROXIDE;SIMETICONE]) ongoing since an unknown date at a dose of 1 dosage form; HYDROGEN PEROXIDE ongoing since an unknown date at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Pain, at a dose of 1 dosage form. At the time of the report, ORAL PAIN (Terrible mouth sores on my tongue, inner lips, and gums.) and ORAL DISCOMFORT (Burning in her mouth) was resolving.            No relevant concomitant medications were reported.   This case was linked to MOD-2021-256827 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up document contains No New Information.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Pyrexia
Clinical narrative: cough; chills; fatigue; fever of 99 degrees; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever of 99 degrees) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 01M20A) for COVID-19 vaccination.     no medical history reported by reporter.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced COUGH (cough), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever of 99 degrees). The patient was treated with DEXTROMETHORPHAN POLISTIREX (ROBITUSSIN 12 HOUR COUGH RELIEF) ongoing since an unknown date at an unspecified dose and frequency; LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN-D) ongoing since an unknown date at an unspecified dose and frequency and ZINC GLUCONATE (COLD-EEZE [ZINC GLUCONATE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, COUGH (cough), CHILLS (chills), FATIGUE (fatigue) and PYREXIA (fever of 99 degrees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2021: Non significant follow up received on 25-MAY-2021, reporter stated that he did not reported any AE
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Dizziness, Pain in extremity, Pyrexia
Clinical narrative: joint pain; body weakness; dizzy; sleepy; legs were painful; fever; soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on her arm), ASTHENIA (body weakness), DIZZINESS (dizzy), SOMNOLENCE (sleepy) and PAIN IN EXTREMITY (legs were painful) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness on her arm) and PYREXIA (fever). On 05-Feb-2021, the patient experienced ASTHENIA (body weakness), DIZZINESS (dizzy), SOMNOLENCE (sleepy) and PAIN IN EXTREMITY (legs were painful). On 06-Feb-2021, the patient experienced ARTHRALGIA (joint pain). At the time of the report, PAIN IN EXTREMITY (soreness on her arm), ASTHENIA (body weakness), DIZZINESS (dizzy), SOMNOLENCE (sleepy), PAIN IN EXTREMITY (legs were painful), ARTHRALGIA (joint pain) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: joint pain; body weakness; dizzy; sleepy; legs were painful; fever; soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on her arm), ASTHENIA (body weakness), DIZZINESS (dizzy), SOMNOLENCE (sleepy) and PAIN IN EXTREMITY (legs were painful) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness on her arm) and PYREXIA (fever). On 05-Feb-2021, the patient experienced ASTHENIA (body weakness), DIZZINESS (dizzy), SOMNOLENCE (sleepy) and PAIN IN EXTREMITY (legs were painful). On 06-Feb-2021, the patient experienced ARTHRALGIA (joint pain). At the time of the report, PAIN IN EXTREMITY (soreness on her arm), ASTHENIA (body weakness), DIZZINESS (dizzy), SOMNOLENCE (sleepy), PAIN IN EXTREMITY (legs were painful), ARTHRALGIA (joint pain) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fluid retention, Pain in extremity
Clinical narrative: Extended down into my hand and up into my shoulder; Kinda fluidy; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), ARTHRALGIA (Extended down into my hand and up into my shoulder) and FLUID RETENTION (Kinda fluidy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Pelvic fracture.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On an unknown date, the patient experienced ARTHRALGIA (Extended down into my hand and up into my shoulder) and FLUID RETENTION (Kinda fluidy). The patient was treated with OXYCODONE HYDROCHLORIDE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]) for Pelvic fracture, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Arm pain), ARTHRALGIA (Extended down into my hand and up into my shoulder) and FLUID RETENTION (Kinda fluidy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever has gotten progressively worse all day long , fever was in the 100s; fever last night/ fever has gotten progressively worse all day long , fever was in the 100s; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever last night/ fever has gotten progressively worse all day long , fever was in the 100s) and PYREXIA (fever has gotten progressively worse all day long , fever was in the 100s) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (fever last night/ fever has gotten progressively worse all day long , fever was in the 100s). On 10-Feb-2021, the patient experienced PYREXIA (fever has gotten progressively worse all day long , fever was in the 100s). At the time of the report, PYREXIA (fever last night/ fever has gotten progressively worse all day long , fever was in the 100s) and PYREXIA (fever has gotten progressively worse all day long , fever was in the 100s) outcome was unknown.            No relevant concomitant medications were reported.   No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.    Reporter did not allow further contact
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: very little reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (very little reaction) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol (takes an unknown statin) and Blood pressure high.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (very little reaction). At the time of the report, VACCINATION COMPLICATION (very little reaction) outcome was unknown.            Treatment information was not provided. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not applicable as the patient received the second dose on 11 Feb 2021.     This case was linked to MOD-2021-052746 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Fever; Sore; Really Tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), PAIN (Sore) and FATIGUE (Really Tired) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (Fever), PAIN (Sore) and FATIGUE (Really Tired). At the time of the report, PYREXIA (Fever), PAIN (Sore) and FATIGUE (Really Tired) outcome was unknown. Not Provided    No relevant concomitant medications were reported.  No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: she felt horrible; tired; right arm started hurting the same day; experiencing a low-grade fever (99.6 F) that is ongoing; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (she felt horrible), FATIGUE (tired), VACCINATION SITE PAIN (right arm started hurting the same day) and PYREXIA (experiencing a low-grade fever (99.6 F) that is ongoing) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Herpes simplex. Concurrent medical conditions included Penicillin allergy, Drug allergy and Food allergy (kiwi). Concomitant products included TRAMADOL, ZOLPIDEM TARTRATE (AMBIEN), ALPRAZOLAM and ACYCLOVIR [ACICLOVIR] for an unknown indication.  On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (right arm started hurting the same day) and PYREXIA (experiencing a low-grade fever (99.6 F) that is ongoing). On 06-Feb-2021, the patient experienced DISCOMFORT (she felt horrible) and FATIGUE (tired). At the time of the report, DISCOMFORT (she felt horrible), FATIGUE (tired), VACCINATION SITE PAIN (right arm started hurting the same day) and PYREXIA (experiencing a low-grade fever (99.6 F) that is ongoing) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment details included Motrin, Tylenol.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site erythema
Clinical narrative: arm is still pink; arm became red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (arm is still pink) and VACCINATION SITE ERYTHEMA (arm became red) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (arm is still pink) and VACCINATION SITE ERYTHEMA (arm became red). At the time of the report, VACCINATION SITE DISCOLOURATION (arm is still pink) and VACCINATION SITE ERYTHEMA (arm became red) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Dizziness, Fatigue
Clinical narrative: Dizziness; Weakness; Chills; joint pain; muscle pain; Headache; overwhelming fatigue; brain fog; nonfunctional; debilitated; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     No medical History Information was reported.     On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain), HEADACHE (Headache), FATIGUE (overwhelming fatigue), FEELING ABNORMAL (brain fog), FEELINGS OF WORTHLESSNESS (nonfunctional) and ASTHENIA (debilitated). At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain), HEADACHE (Headache), FATIGUE (overwhelming fatigue), FEELING ABNORMAL (brain fog), FEELINGS OF WORTHLESSNESS (nonfunctional) and ASTHENIA (debilitated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 09-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     No medical History Information was reported.     On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain), HEADACHE (Headache), FATIGUE (overwhelming fatigue), FEELING ABNORMAL (brain fog), FEELINGS OF WORTHLESSNESS (nonfunctional) and ASTHENIA (debilitated). At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain), HEADACHE (Headache), FATIGUE (overwhelming fatigue), FEELING ABNORMAL (brain fog), FEELINGS OF WORTHLESSNESS (nonfunctional) and ASTHENIA (debilitated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.